PCRX MEXC RealStocks
Own real PCRX shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-17 17:24:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Pacira BioSciences, Inc. (PCRX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $36.49, with a market capitalization of $1.46B and a P/E ratio of 38.59. Over the past 52 weeks, its price has ranged from $18.80 to $36.67. This page covers its latest market performance, valuation, price trends and company information.
$1.46B | |
$36.48 | |
$36.49 | |
$36.46 | |
$36.46 | |
680.23K | |
1.33M | |
38.59 | |
$36.67 | |
$18.80 | |
-- | |
-- |
Pacira BioSciences, Inc. (PCRX) is currently trading at $36.49 as of 2026-11-17 00:31:00, up 0.07% ($0.02) from the previous close of $36.46
During today's regular trading session, PCRX has traded between $36.46 and $36.49, with a trading volume of 680.23K shares. The current price is near the upper end of today's range.
Over the past seven days, Pacira BioSciences, Inc. (PCRX) moved from $36.43 to $36.49, representing a gain of 0.15% ($0.05).
The stock traded between $36.42 and $36.50 during the period. The latest price is near the upper end of the 7-day range, indicating range-bound.
The average daily volume was 1.21 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 99.0%
PCRX is currently trading at $36.49, placing it 99.0% of the way from its 52-week low of $18.80 to its 52-week high of $36.67. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 829 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Pacira BioSciences, Inc. (PCRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to PCRX, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between PCRX shares and USD.
PCRX Shares to USD
1.00 PCRX shares = 36.485 USD
Calculations are estimates based on the latest available price and are for reference only.